A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J Jackson, MD
University of Wisconsin, Madison
Study Chair - William W Busse, MD
University of Wisconsin, Madison
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Ann and Robert Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- St. Louis Children'S Hospital
St Louis, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Nov 2017
- Primary completion
- 20 Apr 2021
- Completion
- 20 Apr 2021
- Last update posted
- 20 Jul 2022
- Registered enrollment
- 335
- Registry id
- NCT03292588
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.